Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation

The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study

(2018) David A Turner et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature

(2018) C.-H. Wu et al.   OSTEOPOROSIS INTERNATIONAL

Characteristics of recurrent fractures

(2018) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Review of the guideline of the American College of Physicians on the treatment of osteoporosis

(2018) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW

(2017) Ruben M.W.A. Drost et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality

(2017) Thach Tran et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis

(2017) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis

(2017) Felicia Cosman et al.   MAYO CLINIC PROCEEDINGS

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

(2017) Kenneth G. Saag et al.   NEW ENGLAND JOURNAL OF MEDICINE

Observations following discontinuation of long-term denosumab therapy

(2017) M. R. McClung et al.   OSTEOPOROSIS INTERNATIONAL

Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS

(2017) Axel Svedbom et al.   QUALITY OF LIFE RESEARCH

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS — 2016

(2016) Pauline M. Camacho et al.   Endocrine Practice

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis

(2016) Paul D. Miller et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

(2016) Gillian D. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Imminent risk of fracture after fracture

(2016) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

A systematic review of intervention thresholds based on FRAX

(2016) John A. Kanis et al.   Archives of Osteoporosis

Residual effect after oral bisphosphonate treatment and healthy adherer effects—the Swedish adherence register analysis (SARA)

(2014) O. Ström et al.   OSTEOPOROSIS INTERNATIONAL

A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis

(2014) Mickaël Hiligsmann et al.   PHARMACOECONOMICS

A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

(2014) Mickaël Hiligsmann et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

(2013) Patrick Haentjens   ANNALS OF INTERNAL MEDICINE

Health Technology Assessment in Osteoporosis

(2013) Mickael Hiligsmann et al.   CALCIFIED TISSUE INTERNATIONAL

The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture

(2013) F. Borgström et al.   OSTEOPOROSIS INTERNATIONAL

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

(2013) Don Husereau et al.   PHARMACOECONOMICS

Economic evaluations in European reimbursement submission guidelines: current status and comparisons

(2013) Andrea Bracco et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland

(2012) K. Lippuner et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2012) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

(2012) J. Jaime Caro et al.   VALUE IN HEALTH

Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

(2012) David M. Eddy et al.   VALUE IN HEALTH

The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis

(2012) Mickaël Hiligsmann et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Análise farmacoeconômica das estratégias de tratamento da osteoporose em mulheres na pós-menopausa: uma revisão sistemática

(2012) Cristina Mariano Ruas Brandão et al.   Revista Brasileira De Reumatologia

Valuing Health for Clinical and Economic Decisions: Directions Relevant for Rheumatologists

(2011) M. J. HARRISON et al.   JOURNAL OF RHEUMATOLOGY

Partial adherence: a new perspective on health economic assessment in osteoporosis

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium

(2011) Mickaël Hiligsmann et al.   PHARMACOECONOMICS

Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications

(2010) Mickaël Hiligsmann et al.   CALCIFIED TISSUE INTERNATIONAL

Cost–Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence

(2010) Mickaël Hiligsmann et al.   VALUE IN HEALTH

Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis

(2009) Mickaël Hiligsmann et al.   VALUE IN HEALTH

Incorporating adherence into health economic modelling of osteoporosis

(2008) O. Ström et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effective osteoporosis treatment thresholds: the United States perspective

(2008) A. N. A. Tosteson et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis

(2006) Carolyn M. Klotzbuecher et al.   JOURNAL OF BONE AND MINERAL RESEARCH